Grassley Articles:

Psychiatric Credibility Takes a Major Nose Dive

The New York Times has just reported on the investigation by Senator Charles Grassley (R-Iowa) into the money paid by Big Pharma to the key researchers promoting the off label use of anti-psychotic medications. It shows that the researchers who have been behind promoting massive off-label use of these powerful drugs to children were on the take from Big Pharma and hiding millions in “consulting fees.”

Read More:  anti-psychotic medications, FDA, Grassley, off-label use